Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | CES2 | O00748 | 7/20 | 0.55 |
| ▸ | CES1 | P23141 | 7/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27483870 | 0.98 | ALDH1A1 (0.71) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| SCHEMBL7869090 | 0.93 | ALDH1A1 (0.65) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| Ethyl Pyruvate SCHEMBL11359579 | 0.93 | ALDH1A1 (0.65) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| SCHEMBL1172378 | 0.89 | MAPT (0.60) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL5711212 | 0.88 | ALDH1A1 (0.69) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| SCHEMBL28248517 | 0.88 | ALDH1A1 (0.59) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| SCHEMBL27611205 | 0.87 | MAPT (0.58) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| SCHEMBL9863135 | 0.86 | ALDH1A1 (0.56) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| SCHEMBL4739675 | 0.86 | ALDH1A1 (0.57) | ALDH1A1MAPTMEN1KMT2ACES2 | |
| SCHEMBL21636278 | 0.86 | ALDH1A1 (0.57) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106884-A1 | PROCESS FOR PREPARING IMMUNOGENIC AZALIDES | ZOETIS SERVICES LLC (US) | 2026-05-21 | — | — | WO | claimed |
| EP-4504813-B1 | SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION | H K WENTWORTH LTD (GB) | 2026-02-11 | — | — | EP | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| US-20250206983-A1 | SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION | H K WENTWORTH LTD (GB) | 2025-06-26 | — | — | US | claimed |
| WO-2025111428-A1 | METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | claimed |
| WO-2025111523-A1 | METHODS OF FORMING CATIONIC POLYMERS USING INITIATORS ACTIVATED ONLY BY ULTRAVIOLET LIGHT | SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) | 2025-05-30 | — | — | WO | claimed |
| US-20250163647-A1 | METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM | SOLENIS TECHNOLOGIES, L.P. (US) | 2025-05-22 | — | — | US | claimed |
| US-20250163190-A1 | METHODS OF FORMING CATIONIC POLYMERS USING INITIATORS ACTIVATED ONLY BY ULTRAVIOLET LIGHT | SOLENIS TECHNOLOGIES, L.P. (US) | 2025-05-22 | — | — | US | claimed |
| US-12286487-B2 | Antibody compounds with reactive arginine and related antibody drug conjugates | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-04-29 | — | — | US | claimed |
| EP-4504813-A1 | SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION | H. K. Wentworth Limited (GB) | 2025-02-12 | — | — | EP | claimed |
| EP-0273202-B1 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | SCOTT EUGENE J VAN (US) | 1995-06-21 | — | — | EP | claimed |
| EP-0599819-A2 | Additives enhancing topical actions of therapeutic agents | Van Scott, Eugene J., Dr. (US) | 1994-06-01 | — | — | EP | claimed |
| WO-1992018116-A1 | COMPOSITIONS COMPRISING 2-HYDROXYCARBOXYLIC ACIDS AND RELATED COMPOUNDS, AND METHODS FOR ALLEVIATING SIGNS OF DERMATOLOGICAL AGING | YU RUEY J (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0508324-A2 | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | Yu, Ruey J., Dr. (US) | 1992-10-14 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| EP-0273202-A2 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | Van Scott, Eugene J., Dr. (US) | 1988-07-06 | — | — | EP | claimed |
| US-4038164-A | PHOTOPOLYMERIZABLE ARYL AND HETEROCYCLIC GLYOXYLATE COMPOSITIONS AND PROCESS | STAUFFER CHEMICAL COMPANY (US) | 1977-07-26 | — | — | US | claimed |
| US-4024296-A | Photocatalyst system and pigmented actinic light polymerizable coating compositions containing the same | PPG INDUSTRIES, INC. (US) | 1977-05-17 | — | — | US | claimed |
| US-4024297-A | Actinic light polymerizable coating compositions | PPG INDUSTRIES, INC. (US) | 1977-05-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12286487-B2 | Antibody compounds with reactive arginine and related antibody drug conjugates | RAB29, RAB39A, RAB5C | ALDH1A1 1868/4885MAPT 1337/4885MEN1 3043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.